Mankind Pharma Planning Acquisition of Bharat Serum and Vaccines from Advent

Mankind Pharma is planning the acquisition of Bharat Serum and Vaccines from private equity firm Advent. Currently, Advent holds a hundred percent stake in Bharat Serum and Vaccines. In November 2019 Advent acquired a seventy-four percent stake in Bharat Serum and Vaccines from Orbimed Asia and Kotak PE.

As reported by CNBC TV18, subsequently, in 2020, Advent completed the acquisition of the remaining twenty-six percent stake, facilitating the exit of the previous promoters. Bharat Serum and Vaccines operates in various sectors including women’s healthcare, assisted reproductive treatment, critical care, and emergency medicines.